English
Home > Products > Citalopram advance intermediate

China Citalopram advance intermediate Factory

Our solutions are greatly recognized and reliable by customers and will fulfill continuously altering financial and social requirements for Citalopram advance intermediate,CAS NO 495-69-2,495-69-2,Citalopram intermediate,Hippuric, The continual availability of substantial grade products and solutions in combination with our fantastic pre- and after-sales services ensures strong competitiveness in an increasingly globalized current market.
Citalopram advance intermediate, Our advantages are our innovation, flexibility and reliability which have been built during last 20 years. We focus on providing service for our clients as a key element in strengthening our long-term relationships. The continual availability of high grade products and solutions in combination with our excellent pre- and after-sales service ensures strong competitiveness in an increasingly globalized market.

Related Products

Hot Products

  • Emtricitabine

    Emtricitabine

    Product Name:Emtricitabine
    Molecular Formula:C8H10FN3O3S
    Molecular Weight;247.25
    CAS Registry Number;143491-57-0
  • Lurasidone hydrochloride

    Lurasidone hydrochloride

    Product Name:Lurasidone hydrochloride
    Molecular Formula:C28H37ClN4O2S
    Molecular Weight;529.14
    CAS Registry Number;367514-88-3
  • Sodium dodecyl sulfate

    Sodium dodecyl sulfate

    Product Name:Sodium dodecyl sulfate
    Molecular Formula:C12H25NaO4S
    Molecular Weight:288.38
    CAS Registry Number:151-21-3
  • Citalopram hydrobromide

    Citalopram hydrobromide

    Product Name:Citalopram hydrobromide
    Molecular Formula:C20H22BrFN2O
    Molecular Weight;405.3
    CAS Registry Number;59729-32-7
  • Vinorelbine

    Vinorelbine

    Product Name:Vinorelbine
    Molecular Formula:C45H54N4O8
    Molecular Weight:778
    CAS Registry Number:71486-22-1
  • 5'-O-(4,4-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite

    5'-O-(4,4-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite

    Product Name:5'-O-(4,4-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
    Molecular Formula:C39H46FN4O8P
    Molecular Weight:748.78
    CAS Registry Number:146954-75-8
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept